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ABSTRACT
Heyde’s syndrome is a form of acquired von Willebrand syndrome that consists of bleeding from intestinal angiodysplasia in the presence 
of aortic stenosis (AS). An association with obstructive hypertrophic cardiomyopathy, rather than AS, by a similar mechanism has also 
been described. We report the case of a 78-year-old woman with chronic anaemia and hypertrophic obstructive cardiomyopathy in whom 
intestinal angiodysplasia with active bleeding was identified by an unconventional method. In this case, the authors describe a different 
approach to reach the correct diagnosis.
LEARNING POINTS
• In patients with anaemia due to gastrointestinal bleeding, a high level of suspicion is crucial to identify the haemorrhagic focus.
• Intestinal angiodysplasia is associated with acquired von Willebrand syndrome. 
• Acquired von Willebrand syndrome secondary to hypertrophic obstructive cardiomyopathy occurs by the same mechanism of aortic 
stenosis.
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CASE REPORT
A 78-year-old woman with a history of hypertrophic obstructive cardiomyopathy causing heart failure (New York Heart Association (NYHA) 
class II) and chronic anaemia diagnosed 3 years previously, presented to the emergency department with a 2-week history of asthenia with 
progressive worsening and melena. 
She had two previous hospitalizations for symptomatic anaemia, requiring red blood cell transfusion. The aetiological study previously 
performed included upper and lower endoscopies and video capsule endoscopy, but an acute haemorrhagic focus was not identified. 
The patient also had a previous medical history of chronic obstructive pulmonary disease (GOLD 1) associated with smoking. In addition, she 
was chronically medicated with esomeprazole 40 mg per day, lisinopril 20 mg per day, furosemide 20 mg per day, ferrous sulphate 525 mg 
per day, salmeterol/fluticasone 25/50 µg twice a day and tiotropium bromide 2.5 µg per day.
At admission, she was prostrate with pale and dehydrated skin and mucous membranes. Hypotension (blood pressure 95/54 mmHg) and 
tachycardia (heart rate 101 bpm) were observed. Cardiac auscultation revealed a systolic murmur with an aortic focus, grade III/VI. 
Laboratory tests (Table 1) demonstrated severe normocytic hypochromic anaemia, and a non-obstructive, non-oliguric acute kidney injury 
(AKIN 2) with an estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease (MDRD) equation of 27.17 
ml/min/1.73 m2. An abnormal coagulation test was also observed, with a prolonged activated prothrombin time (aPTT) but without any 
coagulation factor deficit.
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Table 1. Laboratory tests
An upper endoscopy was performed but again no haemorrhage was identified above the D3–D4 portion of the duodenum. However, despite 
the previous normal endoscopic results, a high clinical suspicion of active gastrointestinal bleeding persisted so it was decided to perform 
technetium-labelled erythrocyte scintigraphy. The results showed a low-output, active haemorrhage in the jejunum. After confirmation of 
active bleeding, a double-balloon enteroscopy was performed to treat the two angiodysplasias found in the jejunum with argon plasma laser 
coagulation.
Transthoracic echocardiography confirmed the previous finding of hypertrophic obstructive cardiomyopathy with asymmetric left 
ventricular hypertrophy with septal predominance and a maximum thickness of 21 mm, systolic anterior motion (SAM) of the mitral valve, 
and obstruction of the left ventricular outflow tract (LVOT) (Fig. 1) with a maximum gradient of 144 mmHg at this level (dynamic obstruction 
pattern) (Fig. 2). Brain natriuretic peptide (BNP) was 332 pg/ml. Electrocardiography revealed sinus rhythm, 101 heart beats per minute and 
Sokolov–Lyon criteria for left ventricular hypertrophy.
Parameters Value Reference
Blood count 1.32×106/µl 3.50–5.50
Haemoglobin 3.5 g/dl 12.0–15.0
Haematocrit 11.7% 36.0–48.0
MCV 88.6 fl 79.0–98.0
MCH 26.5 pg 25.0–35.0
MCHC 29.5 g/dl 30.0–36.0
Reticulocytes 15.8% -
Reticulocyte index 1.45 0.5–2.5
Blood smear Anisocytosis, polychrophilia,
 dacryocytes, target cells
Urea 132 mg/dl 10–50
Creatinine 1.9 mg/dl <1.1
Iron 16 µg/dl 49–151
Ferritin 7 ng/ml 11–307
TIFC 327 µg/dl 250–410
Transferrin 233 mg/dl 192–382
TSAT 5% 20–50
Folic acid 8.4 ng/ml 3.1–19.9
B12 vitamin 104 pg/ml 180–914
LDH 365 IU/l 266–500
BNP 332 pg/ml <100
TP 11.6 seg. 11.6
aPTT 42.4 seg. 29.2
INR 1 -
F VIII 126.6% 50–150
F XI 118.1% 65–150
F IX 111.2% 65–150
F XII 80.7% 50–150
von Willebrand
 antigen
158.1% 42–140.8
Ristocetin cofactor 123.4% 40.3–125.9
Figure 1. Left ventricular outflow tract obstruction 
and systolic anterior motion of the mitral valve
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As a result, gastrointestinal bleeding in the context of angiodysplasia associated with cardiovascular disease induced by acquired von 
Willebrand syndrome (aVWS) was diagnosed. The patient achieved haemodynamic stability after red blood cell transfusion and isotonic 
saline fluid administration. The iron deficiency was treated with ferric carboxymaltose and the vitamin B12 deficiency with cyanocobalamin. 
At discharge, the blood count was stable with Hb of 10.7 g/dl. The patient also continued the beta-blocker started and titrated during 
hospitalization. The patient will be followed up in the cardiology department. 
DISCUSSION
Anaemia is a common diagnosis in clinical practice but is difficult to evaluate as several conditions may be contributing simultaneously. The 
most frequent cause of anaemia is blood loss, but sometimes the bleeding source is not evident so the anamnesis is crucial for deciding which 
investigations should be performed. 
Heyde’s syndrome is a form of aVWS that consists of bleeding from intestinal angiodysplasia in the presence of aortic stenosis (AS) and was 
first described by Edward Heyde in 1958. Shimizu et al. reported acquired von Willebrand factor deficiency in a patient with hypertrophic 
obstructive cardiomyopathy (HOCM) caused by the same mechanism as in AS[1–5]. 
The mechanism reducing von Willebrand factor (VWF) activity can be immune or non-immune. Various cardiovascular diseases, such as, 
HOCM, paravalvular leak after mitral valve replacement and several congenital structural diseases, as well as mechanical circulatory support 
systems, generate excessively high shear stress in the bloodstream. In areas of high turbulence, the VWF multimers become unfolded and 
elongated by the shear stress, becoming susceptible to cleavage by ADAMTS13. Several proteases, including ADAMTS13, cleave VWF when 
cleavage points are exposed. This cleavage results in a reduction in size and in haemostatic competence [6–8]. 
Given the association between aVWS and some medical conditions, patients with symptoms of bleeding and any of the above diseases 
should raise suspicion of aVWS. The bleeding from gastrointestinal angiodysplasia commonly seen in Heyde’s syndrome patients is caused 
by the increased angiogenesis observed in aVWS. Although a causal association between reduced VWF and increased angiogenesis remains 
to be demonstrated, VWF is thought to suppress angiogenesis [7–10]. 
Laboratory tests in aVWS may reveal prolongation of aPTT due to low factor VIII. Laboratory assessment of VWF level, factor VIII and 
ristocetin cofactor activity is appropriate. It is also important to check the VWF multimers, which are decreased in aVWS, although this 
assay is not readily available and so was not used in our particular case [7, 8]. 
Our patient had a previous diagnosis of HOCM, prolonged APTT with normal coagulation factors and evidence of chronic blood loss. 
Although extensive diagnostic investigations had been performed previously, all had failed to identify the location of haemorrhage with 
severe consequences for the patient. 
Figure 2. LV-AO gradient of 144 mmHg denoting 
left ventricular outflow tract obstruction
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The bleeding was accurately located by a diagnostic method not used in the first sets of investigation – a technetium 99m-labeled red blood 
cell scan. Used since the 1970s, it is known to have high false positive and high false negative rates in patients with acute gastrointestinal 
bleeding. However, a different approach to the problem, through a complementary diagnostic examination not so well validated in the 
literature, allowed the correct diagnosis to be made quickly, allowing targeted treatment and a clear gain in quality of life.
CONCLUSION
Although rarely, HOCM is one of the cardiovascular diseases associated with aVWS.
In our patient, the high clinical suspicion and investigative persistence allowed the intestinal haemorrhage to be confirmed as the cause of 
anaemia. The systematic approach was fundamental for correct treatment and led to the connection between the pathologies being made.
The use of an uncommon diagnostic scintigraphy performed with 99mTC-labeled autologous erythrocytes allowed the correct diagnosis to 
be made when endoscopy did not. 
